RBC Capital upgraded Fisher & Paykel Healthcare to Sector Perform from Underperform with a price target of NZ$21, up from NZ$20. The analyst cites valuation for the upgrade after the company maintained its fiscal 2024 outlook.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
